Director, Hematologic Malignancies/Bone Marrow Transplant at Beth Israel Deaconess Medical Center Harvard Medical Faculty Physicians (HMFP) at Beth Israel Deaconess Medical Center
My research interest lies in the field of tumor immunotherapy and its incorporation into bone marrow transplantation. Active projects include the development of dendritic cell tumor fusions to be used as tumor vaccines in clinical trials for multiple myeloma and solid tumor patients. I have also been exploring the number of immune reconstitution post-transplant and studying the impact of cytokine therapy with IL-12 and GM-CSF on this process. I am currently leading a new trial in the use of post-transplant Her2Neu antibody therapy assessing its impact on persistent residual disease. One group is investigating novel approaches to allogeneic transplantation including the use of non-myeloablative approaches.
years treating myeloma: 32
Number of Myeloma Patients Treated Annually:
Details & contact info
330 Brookline Avenue Fenway
Boston, MA, United States, 2215
Send a message to David Avigan, MD